Mutagenicity and loss of heterozygosity at the APRT locus in human lymphoblastoid cells exposed to 3'-azido-3'-deoxythymidine

Mutagenesis

Volumn 15, Issue 5, 2000, Pages 405-410

  Meng, Quanxin ^a   Grosovsky, Andrew J ^b   Shi, Xiaochu ^a   Walker, Vernon E ^a,c  

^a WADSWORTH CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE PHOSPHORIBOSYLTRANSFERASE; DNA; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; PENICILLIN G; STREPTOMYCIN; THYMIDINE KINASE; ZIDOVUDINE;

ARTICLE; ASSAY; AUTOSOME; CELL CLONING; CONTROLLED STUDY; EXPOSURE; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL; MEDICAL RESEARCH; MUTAGENICITY; MUTATION RATE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 0033829788     PISSN: 02678357     EISSN: None     Source Type: Journal    
DOI: 10.1093/mutage/15.5.405     Document Type: Article

References (33)

1. Genotoxicity and mitochondrial damage in human lymphocytic cells chronically exposed to 3'-azido-2',3'-dideoxythymidine
2. Nonclinical toxicology studies with zidovudine: Genetic tests and carcinogenicity bioassays in mice and rats
3. Reduction of maternal-infant transmission of human immunodeficiency virus type I with zidovudine treatment
4. 3'-Azido-2',3'-dideoxythymidine cytotoxicity and metabolism in the human colon tumor cell line HCT-8
5. Induction of micronuclei by low doses of azidothymidine (AZT)
6. Multiorgan transplacental and neonatal carcinogenicity of 3'-azido-2',3'-dideoxythymidine in mice
7. TK mouse model for detecting in vivo mutation in an endogenous, autosomal gene
8. Adenine phosphoribosyltransferase-deficient mice develop 2,8-dihydroxyadenine nephrolithiasis
9. A genetical model for colorectal tumorgenesis
10. Allelic losses in mutations at the aprt locus of human lymphoblastoid cells
11. Genotoxicity of azidothymidine (AZT) in in vitro systems
12. Protection against AZT-induced mutagenesis at the HGPRT locus in a human cell line by WR-151326
13. Osteosarcoma and retinoblastoma: A shared chromosomal mechanism revealing recessive predisposition
14. In vivo loss of heterozygosity in T-cells of B6C3F1 Aprt (+/-) mice
15. Mutation assay at the thymidine kinase locus in diploid human lymphoblasts
16. A comparison of mutation induction at the tk and hprt loci in human lymphoblastoid cells; quantitative differences are due to an additional class of mutations at the autosomal tk locus
17. Relationship between DNA incorporation, mutant frequency and loss of heterozygosity at the TK locus in human lymphoblastoid cells exposed to 3'-azido-3'-deoxythymidine
18. AZT-ddl coexposure potentiates DNA incorporation of AZT and mutagenesis in human cells
19. Multiple-dose erythrocyte micronucleus assays in mice and rats with azidothymidine (AZT)
20. Immunofluorescent localization and quantitation of 3'-azido-3'-deoxythymidine (AZT) incorporated into chromosomal DNA of human, hamster and mouse cell lines
21. Transplacental effects of 3'-azido-2',3'-dideoxythymidine (AZT): Tumorgenicity in mice and genotoxicity in mice and monkeys
22. Incorporation of zidovudine into leukocyte DNA from HIV-1-positive adults and pregnant women and cord blood from infants exposed in utero
23. Induction of micronuclei in mouse bone marrow cells: An evaluation of nucleoside analogues used in the treatment of AIDS
24. Isolation of an APRT heterozygote from TK6 human lymphoblasts: Predominance of multi-locus loss of heterozygosity among spontaneous APRT mutants
25. Recombinant human interferon beta ser protects against zidovudine-induced genetic damage in AIDS patients
26. Targeted breakage of paracentromeric heterochromatin induces chromosomal instability
27. Cellular pharmacology of 3'-azido-3'-deoxythymidine with evidence of incorporation into DNA of human bone marrow cells
28. Genotoxicity of 3'-azido-3'-deoxythymidine in the human lymphoblastoid cell line, TK6: Relationships between DNA incorporation, mutant frequency and spectrum of deletion mutations in HPRT
29. Surveillance of HIV infection and zidovudine use among health care workers after occupational exposure to HIV-infected blood
30. Determination of spontaneous loss of heterozygosity mutations in Aprt heterozygous mice
31. Incorporation of 3'-azido-3'-deoxythymidine into cellular DNA and its removal in a human leukemic cell line
32. Carcinogen-induced loss of heterozygosity at the Aprt locus in somatic cells of the mouse